XNE-13070-26748
2 vaccinations
4 coded responses
11 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 780 / TX
- Registered
- 2021-02-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-23
Registered in v-safe
-
2021-02-23
Dose 1 — Moderna
-
2021-02-23
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessFree text: Burning sensation to the injection site lasted less than an hourMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Light headedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Survey response — days 1–6 daily, dose 1MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
-
2021-03-09
Survey response — day 14, dose 1MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-03-16
-
2021-03-23
Dose 2 — Moderna
- 2021-03-30
- 2021-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Moderna | |
| 2 | 2021-03-23 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-25 | priority 2/3 | |
| 2021-03-09 | priority 2/3 |
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): Burning sensation to the injection site lasted less than an hour
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Light headed
Systemic reaction (other): Dizziness
Release 5 — day 14, dose 1
Symptoms: Headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release